An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19.
Kengo MatsumotoTsutomu NishidaDai NakamatsuMasashi YamamotoKoji FukuiOsamu MorimuraKinya AbeYukiyoshi OkauchiHiromi IwahashiMasami InadaPublished in: Clinics and practice (2024)
The AST level at admission was an independent risk factor for severe disease in hospitalized Japanese patients with COVID-19.